The DNA damage response to non-replicating adeno-associated virus: Centriole overduplication and mitotic catastrophe independent of the spindle checkpoint

Virology

Volumn 400, Issue 2, 2010, Pages 271-286

  Ingemarsdotter, Carin ^a   Keller, Debora ^a   Beard, Peter ^a  

^a EPFL   (Switzerland)

Author keywords

Adeno associated virus; DNA damage response; Mitotic catastrophe; Mitotic spindle checkpoint

Indexed keywords

ATR PROTEIN; BUB1 RELATED PROTEIN; CHECKPOINT KINASE 1; CYCLIN DEPENDENT KINASE; DNA; PROTEIN MAD2; PROTEIN P53;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CENTRIOLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MITOSIS SPINDLE; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION;

CELL CYCLE; CELL LINE, TUMOR; CENTRIOLES; DEPENDOVIRUS; DNA DAMAGE; DNA REPLICATION; HOST-PATHOGEN INTERACTIONS; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS - 2;

EID: 77949567441     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.02.003     Document Type: Article

References (85)

1. Anouja F., Wattiez R., Mousset S., Caillet-Fauquet P. The cytotoxicity of the parvovirus minute virus of mice nonstructural protein NS1 is related to changes in the synthesis and phosphorylation of cell proteins. J. Virol. 1997, 71(6):4671-4678.
2. Berthet C., Raj K., Saudan P., Beard P. How adeno-associated virus Rep78 protein arrests cells completely in S phase. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(38):13634-13639.
3. Blank M., Shiloh Y. Programs for cell death: apoptosis is only one way to go. Cell Cycle 2007, 6(6):686-695.
4. Blasina A., Price B.D., Turenne G.A., McGowan C.H. Caffeine inhibits the checkpoint kinase ATM. Curr. Biol. 1999, 9(19):1135-1138.
5. Block W.D., Merkle D., Meek K., Lees-Miller S.P. Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine. Nucleic Acids Res. 2004, 32(6):1967-1972.
6. Bourke E., Dodson H., Merdes A., Cuffe L., Zachos G., Walker M., Gillespie D., Morrison C.G. DNA damage induces Chk1-dependent centrosome amplification. EMBO Rep. 2007, 8(6):603-609.
7. Casper A.M., Nghiem P., Arlt M.F., Glover T.W. ATR regulates fragile site stability. Cell 2002, 111(6):779-789.
8. Chen Z., Indjeian V.B., McManus M., Wang L., Dynlacht B.D. CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev. Cell 2002, 3(3):339-350.
9. Cheung H.W., Jin D.Y., Ling M.T., Wong Y.C., Wang Q., Tsao S.W., Wang X. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells. Cancer Res. 2005, 65(4):1450-1458.
10. Chin G.M., Herbst R. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint. Mol. Cancer Ther. 2006, 5(10):2580-2591.
11. Dodson H., Bourke E., Jeffers L.J., Vagnarelli P., Sonoda E., Takeda S., Earnshaw W.C., Merdes A., Morrison C. Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. Embo J. 2004, 23(19):3864-3873.
12. Dodson H., Wheatley S.P., Morrison C.G. Involvement of centrosome amplification in radiation-induced mitotic catastrophe. Cell Cycle 2007, 6(3):364-370.
13. Dowling M., Voong K.R., Kim M., Keutmann M.K., Harris E., Kao G.D. Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents. Cancer Biol. Ther. 2005, 4(2):197-206.
14. Duensing A., Liu Y., Tseng M., Malumbres M., Barbacid M., Duensing S. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication. Oncogene 2006, 25(20):2943-2949.
15. Eom Y.W., Kim M.A., Park S.S., Goo M.J., Kwon H.J., Sohn S., Kim W.H., Yoon G., Choi K.S. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 2005, 24(30):4765-4777.
16. Fang Y., Liu T., Wang X., Yang Y.M., Deng H., Kunicki J., Traganos F., Darzynkiewicz Z., Lu L., Dai W. BubR1 is involved in regulation of DNA damage responses. Oncogene 2006, 25(25):3598-3605.
17. Foukas L.C., Daniele N., Ktori C., Anderson K.E., Jensen J., Shepherd P.R. Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J. Biol. Chem. 2002, 277(40):37124-37130.
18. Fragkos M., Breuleux M., Clement N., Beard P. Recombinant adeno-associated viral vectors are deficient in provoking a DNA damage response. J. Virol. 2008, 82(15):7379-7387.
19. Fragkos M., Jurvansuu J., Beard P. H2AX is required for cell cycle arrest via the p53/p21 pathway. Mol. Cell. Biol. 2009, 29(10):2828-2840.
20. Fry A.M., Mayor T., Meraldi P., Stierhof Y.D., Tanaka K., Nigg E.A. C-Nap1, a novel centrosomal coiled-coil protein and candidate substrate of the cell cycle-regulated protein kinase Nek2. J. Cell Biol. 1998, 141(7):1563-1574.
21. Garner E., Martinon F., Tschopp J., Beard P., Raj K. Cells with defective p53-p21-pRb pathway are susceptible to apoptosis induced by p84N5 via caspase-6. Cancer Res. 2007, 67(16):7631-7637.
22. Gascoigne K.E., Taylor S.S. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008, 14(2):111-122.
23. Hinchcliffe E.H., Li C., Thompson E.A., Maller J.L., Sluder G. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 1999, 283(5403):851-854.
24. Hut H.M., Lemstra W., Blaauw E.H., Van Cappellen G.W., Kampinga H.H., Sibon O.C. Centrosomes split in the presence of impaired DNA integrity during mitosis. Mol. Biol. Cell 2003, 14(5):1993-2004.
25. Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massague J., Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 1995, 376(6538):313-320.
26. Jurvansuu J., Fragkos M., Ingemarsdotter C., Beard P. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling. J. Mol. Biol. 2007, 372(2):397-406.
27. Jurvansuu J., Raj K., Stasiak A., Beard P. Viral transport of DNA damage that mimics a stalled replication fork. J. Virol. 2005, 79(1):569-580.
28. Kanda T., Sullivan K.F., Wahl G.M. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr. Biol. 1998, 8(7):377-385.
29. Katsura M., Tsuruga T., Date O., Yoshihara T., Ishida M., Tomoda Y., Okajima M., Takaku M., Kurumizaka H., Kinomura A., Mishima H.K., Miyagawa K. The ATR-Chk1 pathway plays a role in the generation of centrosome aberrations induced by Rad51C dysfunction. Nucleic Acids Res. 2009, 37(12):3959-3968.
30. Kawamura K., Fujikawa-Yamamoto K., Ozaki M., Iwabuchi K., Nakashima H., Domiki C., Morita N., Inoue M., Tokunaga K., Shiba N., Ikeda R., Suzuki K. Centrosome hyperamplification and chromosomal damage after exposure to radiation. Oncology 2004, 67(5-6):460-470.
31. Kienitz A., Vogel C., Morales I., Muller R., Bastians H. Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol. Oncogene 2005, 24(26):4301-4310.
32. Kornitzer D., Sharf R., Kleinberger T. Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in Saccharomyces cerevisiae and interacts with the anaphase-promoting complex/cyclosome. J. Cell Biol. 2001, 154(2):331-344.
33. Kramer A., Mailand N., Lukas C., Syljuasen R.G., Wilkinson C.J., Nigg E.A., Bartek J., Lukas J. Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase. Nat. Cell Biol. 2004, 6(9):884-891.
34. Lacey K.R., Jackson P.K., Stearns T. Cyclin-dependent kinase control of centrosome duplication. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(6):2817-2822.
35. Lee E.A., Keutmann M.K., Dowling M.L., Harris E., Chan G., Kao G.D. Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells. Mol. Cancer Ther. 2004, 3(6):661-669.
36. Li Y., Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 1996, 274(5285):246-248.
37. Lilley C.E., Schwartz R.A., Weitzman M.D. Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol. 2007, 15(3):119-126.
38. Loffler H., Bochtler T., Fritz B., Tews B., Ho A.D., Lukas J., Bartek J., Kramer A. DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint function. Cell Cycle 2007, 6(20):2541-2548.
39. Masuda A., Maeno K., Nakagawa T., Saito H., Takahashi T. Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers. Am. J. Pathol. 2003, 163(3):1109-1116.
40. Matsumoto Y., Hayashi K., Nishida E. Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr. Biol. 1999, 9(8):429-432.
41. Maude S.L., Enders G.H. Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response. Cancer Res. 2005, 65(3):780-786.
42. Meijer L., Borgne A., Mulner O., Chong J.P., Blow J.J., Inagaki N., Inagaki M., Delcros J.G., Moulinoux J.P. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 1997, 243(1-2):527-536.
43. Meraldi P., Lukas J., Fry A.M., Bartek J., Nigg E.A. Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A. Nat. Cell Biol. 1999, 1(2):88-93.
44. Middendorp S., Kuntziger T., Abraham Y., Holmes S., Bordes N., Paintrand M., Paoletti A., Bornens M. A role for centrin 3 in centrosome reproduction. J. Cell Biol. 2000, 148(3):405-416.
45. Morita E., Nakashima A., Asao H., Sato H., Sugamura K. Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase. J. Virol. 2003, 77(5):2915-2921.
46. Morita E., Tada K., Chisaka H., Asao H., Sato H., Yaegashi N., Sugamura K. Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins. J. Virol. 2001, 75(16):7555-7563.
47. Nabha S.M., Mohammad R.M., Dandashi M.H., Coupaye-Gerard B., Aboukameel A., Pettit G.R., Al-Katib A.M. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage. Clin. Cancer Res. 2002, 8(8):2735-2741.
48. Nghiem P., Park P.K., Kim Y., Vaziri C., Schreiber S.L. ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(16):9092-9097.
49. Nghiem P., Park P.K., Kim Ys Y.S., Desai B.N., Schreiber S.L. ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint. J. Biol. Chem. 2002, 277(6):4428-4434.
50. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nat. Rev. Cancer 2002, 2(11):815-825.
51. Nitta M., Kobayashi O., Honda S., Hirota T., Kuninaka S., Marumoto T., Ushio Y., Saya H. Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents. Oncogene 2004, 23(39):6548-6558.
52. Okuda M., Horn H.F., Tarapore P., Tokuyama Y., Smulian A.G., Chan P.K., Knudsen E.S., Hofmann I.A., Snyder J.D., Bove K.E., Fukasawa K. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 2000, 103(1):127-140.
53. Op De Beeck A., Anouja F., Mousset S., Rommelaere J., Caillet-Fauquet P. The nonstructural proteins of the autonomous parvovirus minute virus of mice interfere with the cell cycle, inducing accumulation in G2. Cell Growth Differ. 1995, 6(7):781-787.
54. Park Y.B., Park M.J., Kimura K., Shimizu K., Lee S.H., Yokota J. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet. Cytogenet. 2002, 133(2):105-111.
55. Peters J.M. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat. Rev. Mol. Cell Biol. 2006, 7(9):644-656.
56. Raj K., Ogston P., Beard P. Virus-mediated killing of cells that lack p53 activity. Nature 2001, 412(6850):914-917.
57. Robinson H.M., Black E.J., Brown R., Gillespie D.A. DNA mismatch repair and Chk1-dependent centrosome amplification in response to DNA alkylation damage. Cell Cycle 2007, 6(8):982-992.
58. Roninson I.B., Broude E.V., Chang B.D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat. 2001, 4(5):303-313.
59. Rudolph B., Saffrich R., Zwicker J., Henglein B., Muller R., Ansorge W., Eilers M. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. Embo J. 1996, 15(12):3065-3076.
60. Sarkaria J.N., Busby E.C., Tibbetts R.S., Roos P., Taya Y., Karnitz L.M., Abraham R.T. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 1999, 59(17):4375-4382.
61. Sato N., Mizumoto K., Nakamura M., Tanaka M. Radiation-induced centrosome overduplication and multiple mitotic spindles in human tumor cells. Exp. Cell Res. 2000, 255(2):321-326.
62. Sato N., Mizumoto K., Nakamura M., Ueno H., Minamishima Y.A., Farber J.L., Tanaka M. A possible role for centrosome overduplication in radiation-induced cell death. Oncogene 2000, 19(46):5281-5290.
63. Saudan P., Vlach J., Beard P. Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. Embo J. 2000, 19(16):4351-4361.
64. Saunders W. Centrosomal amplification and spindle multipolarity in cancer cells. Semin. Cancer Biol. 2005, 15(1):25-32.
65. Schmidt M., Afione S., Kotin R.M. Adeno-associated virus type 2 Rep78 induces apoptosis through caspase activation independently of p53. J. Virol. 2000, 74(20):9441-9450.
66. Sihn C.R., Suh E.J., Lee K.H., Kim T.Y., Kim S.H. p55CDC/hCDC20 mutant induces mitotic catastrophe by inhibiting the MAD2-dependent spindle checkpoint activity in tumor cells. Cancer Lett. 2003, 201(2):203-210.
67. Sudo T., Nitta M., Saya H., Ueno N.T. Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Res. 2004, 64(7):2502-2508.
68. Tao W., South V.J., Diehl R.E., Davide J.P., Sepp-Lorenzino L., Fraley M.E., Arrington K.L., Lobell R.B. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis. Mol. Cell. Biol. 2007, 27(2):689-698.
69. Tao W., South V.J., Zhang Y., Davide J.P., Farrell L., Kohl N.E., Sepp-Lorenzino L., Lobell R.B. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell 2005, 8(1):49-59.
70. Taylor S.S., McKeon F. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 1997, 89(5):727-735.
71. Teodoro J.G., Heilman D.W., Parker A.E., Green M.R. The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes Dev. 2004, 18:1952-1957.
72. Tibelius A., Marhold J., Zentgraf H., Heilig C.E., Neitzel H., Ducommun B., Rauch A., Ho A.D., Bartek J., Kramer A. Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1. J. Cell Biol. 2009, 185(7):1149-1157.
73. Vitale I., Antoccia A., Cenciarelli C., Crateri P., Meschini S., Arancia G., Pisano C., Tanzarella C. Combretastatin CA-4 and combretastatin derivative induce mitotic catastrophe dependent on spindle checkpoint and caspase-3 activation in non-small cell lung cancer cells. Apoptosis 2007, 12(1):155-166.
74. Vogel C., Hager C., Bastians H. Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation. Cancer Res. 2007, 67(1):339-345.
75. Vogel C., Kienitz A., Muller R., Bastians H. The mitotic spindle checkpoint is a critical determinant for topoisomerase-based chemotherapy. J. Biol. Chem. 2005, 280(6):4025-4028.
76. Winocour E., Callaham M.F., Huberman E. Perturbation of the cell cycle by adeno-associated virus. Virology 1988, 167(2):393-399.
77. Xiao Z., Chen Z., Gunasekera A.H., Sowin T.J., Rosenberg S.H., Fesik S., Zhang H. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J. Biol. Chem. 2003, 278(24):21767-21773.
78. Xie A., Scully R. Hijacking the DNA damage response to enhance viral replication: gamma-herpesvirus 68 orf36 phosphorylates histone H2AX. Mol. Cell 2007, 27(2):178-179.
79. Yakobson B., Koch T., Winocour E. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J. Virol. 1987, 61(4):972-981.
80. Zhang P., Castedo M., Tao Y., Violot D., Metivier D., Deutsch E., Kroemer G., Bourhis J. Caspase independence of radio-induced cell death. Oncogene 2006, 25(59):7758-7770.
81. Zhang Y.W., Otterness D.M., Chiang G.G., Xie W., Liu Y.C., Mercurio F., Abraham R.T. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol. Cell 2005, 19(5):607-618.
82. Zhao H., Watkins J.L., Piwnica-Worms H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(23):14795-14800.
83. Zhou B.B., Bartek J. Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nat. Rev. Cancer 2004, 4(3):216-225.
84. Zhou B.B., Chaturvedi P., Spring K., Scott S.P., Johanson R.A., Mishra R., Mattern M.R., Winkler J.D., Khanna K.K. Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem. 2000, 275(14):10342-10348.
85. Ziv Y., Bar-Shira A., Pecker I., Russell P., Jorgensen T.J., Tsarfati I., Shiloh Y. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 1997, 15(2):159-167.